Cannabinoid CB(1) receptor and gastric acid secretion.

Francesca Borrelli
Author Information

Abstract

No abstract text available.

References

  1. Curr Opin Pharmacol. 2001 Dec;1(6):597-603 [PMID: 11757815]
  2. Gen Pharmacol. 1996 Jul;27(5):905-9 [PMID: 8842698]
  3. N Engl J Med. 2006 Mar 2;354(9):974-5; author reply [PMID: 16510755]
  4. Dig Dis Sci. 2006 Feb;51(2):310-7 [PMID: 16534674]
  5. Curr Opin Investig Drugs. 2006 Apr;7(4):312-8 [PMID: 16625817]
  6. Curr Opin Pharmacol. 2004 Dec;4(6):572-9 [PMID: 15525546]

MeSH Term

Animals
Benzoxazines
Biomarkers
Calcium Channel Blockers
Enzyme Inhibitors
Gastric Acid
Gastric Mucosa
Morpholines
Naphthalenes
Ouabain
Piperidines
Pyrazoles
Rats
Receptor, Cannabinoid, CB1
Rimonabant
Stomach

Chemicals

Benzoxazines
Biomarkers
Calcium Channel Blockers
Enzyme Inhibitors
Morpholines
Naphthalenes
Piperidines
Pyrazoles
Receptor, Cannabinoid, CB1
Ouabain
(3R)-((2,3-dihydro-5-methyl-3-((4-morpholinyl)methyl)pyrrolo-(1,2,3-de)-1,4-benzoxazin-6-yl)(1-naphthalenyl))methanone
Rimonabant

Word Cloud

Created with Highcharts 10.0.0CannabinoidCB1receptorgastricacidsecretion

Similar Articles

Cited By